ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,Y
9,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
10,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
11,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
12,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
14,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
15,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
16,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
17,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
19,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
21,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
23,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
23,3,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
23,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
24,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
26,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
27,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
30,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
31,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
32,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
32,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
34,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
35,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
36,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
40,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
41,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
42,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
46,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
47,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
48,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
48,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
50,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
52,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
53,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
54,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
55,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
56,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
57,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
57,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
58,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
58,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
59,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
59,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
60,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
60,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
62,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
63,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
64,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
65,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
66,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
68,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
68,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
69,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
70,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
71,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
72,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
73,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
74,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
75,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
76,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
77,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
78,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
80,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
81,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
82,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
83,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
84,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
85,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
86,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
89,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
90,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
92,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
93,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
93,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
94,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
95,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
95,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
96,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
96,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
97,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
98,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
98,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
99,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
101,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
101,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
101,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
102,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
103,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
103,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
104,2,Ischaemic skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
104,3,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
105,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
106,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
107,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
108,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
108,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
109,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
111,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
112,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
112,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
112,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
112,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
113,1,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
115,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
115,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
116,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
117,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
118,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
118,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
118,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
119,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
120,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
120,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
120,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
121,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
121,2,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
121,3,Scrotal swelling,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
121,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
122,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
122,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
123,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
124,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
125,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
125,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
125,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
125,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
126,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
127,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
127,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
129,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
129,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
130,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
131,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
132,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
133,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
133,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
134,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
135,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
136,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
137,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
138,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
139,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
140,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
140,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
140,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
140,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
140,8,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
140,9,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
140,10,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
140,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
140,12,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,13,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
140,14,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
140,15,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
140,16,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
140,17,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
141,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
141,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
142,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
143,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
143,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
144,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
144,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
144,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
144,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
145,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
146,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
146,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
147,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
147,2,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
147,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
147,4,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
148,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
148,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
149,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
149,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
150,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
151,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
152,2,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
153,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
155,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
156,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
156,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
156,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
157,1,Acute disseminated encephalomyelitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
157,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
157,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
157,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
158,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
159,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
159,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
159,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
160,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
161,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
162,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
163,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
164,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
165,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
165,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
166,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
167,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
167,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
167,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
168,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
169,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
169,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
169,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
169,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
169,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
169,7,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
169,8,Headache,Headaches NEC,Headaches,Nerv,N
169,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,10,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
169,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
170,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
170,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
170,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
170,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
170,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
172,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
172,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
172,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,1,Acne,Acnes,Skin appendage conditions,Skin,N
173,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
174,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
174,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
175,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
175,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
176,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
176,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
177,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
178,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
178,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
179,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
179,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
179,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
179,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
179,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
179,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
181,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
181,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
181,4,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
181,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
182,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
182,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
182,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
183,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,1,Headache,Headaches NEC,Headaches,Nerv,N
185,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
185,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
185,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
187,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
187,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
188,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
189,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
190,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
191,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
191,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
191,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
193,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
194,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
194,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
195,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
196,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
196,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
197,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
197,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
198,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
198,2,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
199,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
200,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
200,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
202,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
202,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
202,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
203,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
203,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
203,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
203,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
205,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
205,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
205,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
205,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,5,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
205,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
205,7,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
206,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
207,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
207,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
207,3,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
208,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
209,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
211,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
211,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
212,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
212,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
213,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
214,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
214,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
214,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
215,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
216,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
216,2,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
216,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
216,4,Application site scab,Application site reactions,Administration site reactions,Genrl,N
216,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
217,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
217,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
218,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
218,3,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
218,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
218,5,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
218,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
218,7,Superficial injury of eye,Eye injuries NEC,Injuries NEC,Inj&P,N
219,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
219,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
219,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
219,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
220,1,Arterial stenosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
220,2,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
220,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
221,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
221,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
221,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
221,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
222,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
222,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
223,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
224,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
224,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
225,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
226,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
226,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
226,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
226,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
227,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
228,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
228,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
228,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
228,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
228,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
229,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
229,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
229,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
230,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
230,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
230,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
230,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
231,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
231,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
231,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
232,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
232,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
232,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
233,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
234,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
234,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
235,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
236,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
237,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
238,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
239,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
240,1,Conjunctivitis allergic,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
241,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
242,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
242,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
244,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
245,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
245,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
245,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
245,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
245,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
246,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
247,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
247,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
247,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
247,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
247,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
247,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
247,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
247,8,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
248,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
248,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
248,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
249,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
249,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
249,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
249,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
250,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
251,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
252,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
253,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
254,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
255,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
255,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
256,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
257,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
257,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
258,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
260,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
261,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
262,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
263,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
263,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
264,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
265,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
265,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
265,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
265,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
267,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
267,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
268,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
269,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
269,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
269,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
269,4,Superficial injury of eye,Eye injuries NEC,Injuries NEC,Inj&P,N
270,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
270,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
271,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
272,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
273,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
274,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
275,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
276,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
277,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
277,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
277,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
277,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
277,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
277,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
278,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
278,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
279,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
280,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
280,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
281,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
282,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
282,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
283,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
283,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
284,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
284,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
284,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
285,1,Vulvovaginal rash,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
285,2,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
286,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
286,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
286,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
287,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
287,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
288,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
288,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
290,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
290,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
291,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
291,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
291,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
293,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
293,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
293,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
293,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
294,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
294,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
295,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
295,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
296,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
297,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
297,2,Ocular neoplasm,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
297,3,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
298,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
298,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
299,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
299,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
299,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
299,4,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
299,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
300,1,Urticaria contact,Urticarias,Angioedema and urticaria,Skin,N
301,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
301,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
301,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
301,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
301,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
301,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
302,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
302,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
302,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
303,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
304,2,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
304,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
304,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
305,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
305,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
306,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
307,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
307,2,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
308,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
309,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
309,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
309,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
309,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
310,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
310,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
311,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
312,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
312,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
312,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
312,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
313,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
313,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
313,3,Diabetic foot,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
313,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
313,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
314,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
314,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
314,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
314,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
315,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
315,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
315,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
315,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
316,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
317,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
318,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
318,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
319,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
320,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
321,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
321,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
322,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
323,2,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
323,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
323,4,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
323,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
323,6,Respiratory tract irritation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
323,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
324,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
324,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
324,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
325,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
326,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
326,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
327,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
327,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
327,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
328,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
329,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
329,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
330,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
330,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
331,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
331,3,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
332,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
332,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
334,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
334,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
334,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
334,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
335,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
335,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
336,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
336,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
336,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
337,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
338,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
339,1,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
339,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
339,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
339,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
340,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
341,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
341,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
341,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
342,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
342,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
342,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
343,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
343,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
344,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
344,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
344,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
344,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
345,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
345,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
346,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
346,2,Eyelid injury,Eye injuries NEC,Injuries NEC,Inj&P,N
346,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
347,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
347,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
347,3,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
347,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
348,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
348,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
349,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
349,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
350,1,Bladder injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
351,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
352,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
353,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
353,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
353,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
353,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
354,1,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
355,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
356,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
356,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
356,3,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
356,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
357,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
358,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
358,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
358,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
359,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
359,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
359,3,Packaging design issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
359,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
360,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
361,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
362,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
362,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
362,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
362,4,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
362,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
362,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
362,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
362,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
362,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
363,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
363,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
364,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
364,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
366,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
367,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
368,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
368,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
368,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
368,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
368,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
368,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
369,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
370,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
371,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
371,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
372,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
372,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
373,1,Accidental death,Death and sudden death,Fatal outcomes,Genrl,Y
373,2,Respiratory fume inhalation disorder,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
373,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
374,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
374,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
374,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
374,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
374,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
375,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
375,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
375,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
376,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
376,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
376,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
376,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
377,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
377,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
377,3,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
377,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
377,5,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
378,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
378,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
379,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
380,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
380,3,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
381,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
381,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
382,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
382,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
383,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
384,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
384,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,Y
385,1,Burns fourth degree,Thermal burns,Injuries by physical agents,Inj&P,Y
385,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
386,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
387,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
388,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
389,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
389,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
390,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
391,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
391,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
391,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
392,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
393,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
394,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
394,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
395,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
395,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
395,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
395,4,Pterygium,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
396,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
396,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
396,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
396,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
396,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
397,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
398,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
398,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
398,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
399,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
399,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
399,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
400,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
401,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
401,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
402,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
402,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
403,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
404,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
404,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
404,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
405,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
405,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
406,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
406,2,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
406,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
407,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
408,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
409,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
409,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
409,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
409,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
409,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
410,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
410,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
410,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
410,5,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
410,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
411,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
412,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
413,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
413,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
414,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
415,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
415,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
416,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
416,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
416,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
416,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
417,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
417,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
417,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
418,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
418,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
419,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
420,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
420,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
421,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
422,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
423,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
424,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
425,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
426,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
426,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
426,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
427,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
428,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
429,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
429,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
429,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
430,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
430,2,Pneumonia lipoid,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
430,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
431,1,Pneumonia lipoid,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
432,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
433,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
434,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
434,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
435,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
437,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
438,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
439,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
439,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
439,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
440,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
440,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
441,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
442,1,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
443,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
443,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
443,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
444,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
444,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
445,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
445,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
445,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
446,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
447,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
448,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
448,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
448,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
448,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
449,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
449,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
449,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
450,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
451,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
452,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
453,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
453,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
453,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
454,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
454,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
455,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
455,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
456,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
457,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
457,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
458,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
459,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
459,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
459,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
459,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
459,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
459,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
460,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
460,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
461,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
462,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
463,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
463,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
463,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
463,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
463,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
464,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
464,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
464,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
465,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
466,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
466,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
468,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
469,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
469,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
470,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
471,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
472,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
473,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
473,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
473,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
473,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
473,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
473,6,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
473,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
473,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
474,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
475,1,Body tinea,Tinea infections,Fungal infectious disorders,Infec,N
475,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
475,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
475,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
476,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
476,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
476,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
476,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
476,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
476,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
476,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
476,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
476,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
476,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
476,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
476,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
476,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
476,14,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
477,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
478,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
478,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
478,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
479,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
480,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
480,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
481,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
481,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
481,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
481,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
481,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
482,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
483,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
483,2,Scrotal erythema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
483,3,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
483,4,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
484,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
485,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
486,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
486,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
486,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
487,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
487,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
487,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
487,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
489,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
489,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
489,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
489,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
489,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
490,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
490,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
491,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
492,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
493,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
493,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
494,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
495,1,Device dependence,Disability issues,Lifestyle issues,SocCi,N
495,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
496,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
497,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
497,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
497,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
497,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
498,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
499,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
500,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
500,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
500,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
501,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
501,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
502,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
502,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
502,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
502,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
503,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
503,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
503,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
504,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
506,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
507,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
507,2,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
508,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
509,1,Acne pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
509,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
510,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
510,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
510,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
510,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
511,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
512,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
512,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
513,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
513,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
513,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
514,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
515,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
516,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
517,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
518,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
519,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
519,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
520,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
521,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
521,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
521,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
522,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
522,2,Lipogranuloma,Inflammations,General system disorders NEC,Genrl,N
522,3,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
523,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
523,2,Lipogranuloma,Inflammations,General system disorders NEC,Genrl,N
523,3,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
524,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
524,2,Lipogranuloma,Inflammations,General system disorders NEC,Genrl,N
524,3,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
524,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
524,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
525,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
525,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
526,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
527,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
528,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
528,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
529,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
529,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
529,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
530,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
530,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
531,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
531,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
531,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
531,4,Headache,Headaches NEC,Headaches,Nerv,N
531,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
531,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
531,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
532,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
532,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
533,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
533,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
534,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
534,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
534,3,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
535,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
535,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
535,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
535,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
535,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
537,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
537,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
537,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
537,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
538,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
538,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
539,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
539,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
540,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
540,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
541,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
542,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
542,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
542,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
543,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
543,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
544,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
546,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
546,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
546,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
546,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
547,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
547,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
547,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
548,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
548,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
548,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
548,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
549,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
550,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
550,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
552,1,Acne,Acnes,Skin appendage conditions,Skin,N
552,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
552,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
552,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
552,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
552,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
552,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
552,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
552,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
552,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
552,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
552,13,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
552,14,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
552,15,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
552,16,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
552,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
552,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
552,19,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
553,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
553,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
554,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
554,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
554,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
555,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
555,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
555,3,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
556,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
556,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
556,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
556,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
557,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
557,2,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
557,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
557,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
558,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
558,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
558,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
559,1,Autoimmune dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
559,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
559,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
559,4,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
559,5,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
560,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
560,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
561,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
561,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
562,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
562,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
563,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
564,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
565,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
565,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
565,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
565,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
566,1,Madarosis,Alopecias,Skin appendage conditions,Skin,N
567,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
567,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
567,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
568,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
569,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
569,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
570,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
571,1,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
571,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
572,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
572,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
572,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
572,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
573,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
574,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
574,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
574,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
574,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
574,5,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
575,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
576,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
577,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
578,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
579,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
580,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
580,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
580,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
580,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
580,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
580,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
581,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
581,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
582,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
582,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
583,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
583,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
583,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
583,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
583,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
583,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
583,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
583,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
584,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
585,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
586,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
587,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
587,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
587,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
587,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
587,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
588,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
589,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
589,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
589,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
590,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
591,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
591,2,Anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
591,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
591,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
591,5,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
591,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
591,7,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
591,8,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
591,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
591,10,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
591,11,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
591,12,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
591,13,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
591,14,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
591,15,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
591,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,17,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
591,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
591,19,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
592,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
593,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
594,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
594,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
594,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
595,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
595,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
596,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
596,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
597,1,Periorbital infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
597,2,Product cleaning inadequate,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
597,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
598,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
598,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
598,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
599,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
599,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
600,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
601,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
602,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
603,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
603,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
603,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
603,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
603,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
604,1,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
604,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
605,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
606,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
607,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
608,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
609,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
610,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
610,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
610,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
611,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
611,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
612,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
613,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
613,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
614,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
614,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
614,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
614,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
615,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
616,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
617,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
618,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
618,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
618,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
619,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
620,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
620,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
620,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
620,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
620,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
621,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
622,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
623,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
624,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
624,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
624,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
624,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
625,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
625,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
626,1,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
626,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
627,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
627,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
628,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
629,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
630,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
631,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
631,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
631,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
631,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
631,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
631,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
632,1,Atopic keratoconjunctivitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
633,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
633,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
634,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
635,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
636,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
637,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
637,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
637,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
637,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
638,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
638,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
639,1,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
640,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
641,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
642,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
643,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
643,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
644,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
645,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
646,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
647,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
648,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
649,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
650,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
650,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
651,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
651,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
652,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
652,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
652,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
652,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
653,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
653,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
653,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
654,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
655,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
656,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
656,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
656,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
657,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
657,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
657,3,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
657,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
658,1,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
658,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
658,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
659,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
660,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
661,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
661,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
662,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
663,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
663,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
664,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
664,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
664,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
665,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
665,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
666,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
666,2,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
666,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
666,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
667,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
668,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
668,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
668,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
669,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
669,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
669,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
670,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
670,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
670,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
671,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
671,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
671,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
673,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
673,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
673,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
674,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
675,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
675,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
676,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
677,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
678,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
679,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
680,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
681,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
681,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
682,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
682,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
682,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
683,1,Ocular surface disease,Ocular disorders NEC,Eye disorders NEC,Eye,N
684,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
684,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
684,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
684,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
684,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
684,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
685,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
685,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
685,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
686,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
687,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
687,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
688,1,Chemical peel of skin,Skin and subcutaneous tissue therapeutic procedures NEC,Skin and subcutaneous tissue therapeutic procedures,Surg,N
688,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
689,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
690,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
690,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
691,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
691,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
691,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
692,1,Ocular surface disease,Ocular disorders NEC,Eye disorders NEC,Eye,N
693,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
693,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
694,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
695,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
696,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
697,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
698,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
698,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
698,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
698,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
699,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
699,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
700,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
701,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
701,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
702,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
702,2,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
702,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
702,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
702,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
702,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
703,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
704,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
704,2,Product label on wrong product,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
705,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
706,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
706,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
706,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
706,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
707,1,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
707,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
708,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
708,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
709,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
710,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
710,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
710,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
710,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
711,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
711,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
711,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
711,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
712,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
713,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
713,2,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
714,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
714,2,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
715,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
716,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
717,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
717,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
718,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
718,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
718,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
718,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
718,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
719,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
720,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
720,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
720,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
721,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
721,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
721,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
722,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
723,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
723,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
723,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
723,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
723,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
723,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
723,7,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
724,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
724,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
725,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
726,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
727,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
727,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
727,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
729,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
729,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
730,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
731,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
732,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
733,1,Ocular surface disease,Ocular disorders NEC,Eye disorders NEC,Eye,N
734,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
735,1,Migraine,Migraine headaches,Headaches,Nerv,N
735,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
736,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
737,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
738,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
738,2,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
739,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
740,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
741,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
742,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
743,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
744,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
745,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
745,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
745,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
745,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
745,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
746,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
746,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
747,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
747,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
747,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
748,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
748,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
748,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
749,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
750,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
751,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
751,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
752,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
752,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
752,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
752,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
753,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
753,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
754,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
755,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,3,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
756,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
757,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
758,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
758,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
759,1,Dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
760,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
761,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
761,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
761,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
761,4,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
762,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
762,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
762,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
763,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
763,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
764,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
765,1,Migraine,Migraine headaches,Headaches,Nerv,N
766,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
767,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
768,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
769,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
769,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
769,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
769,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
769,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
770,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
770,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
770,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
770,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
770,5,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
770,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
770,7,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
770,8,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
771,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
772,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
773,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
774,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
774,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
775,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
776,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
777,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
778,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
779,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
780,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
781,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
782,2,Deafness,Hearing losses,Hearing disorders,Ear,N
782,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
782,4,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
782,5,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
782,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
782,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
782,8,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
782,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
782,10,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
783,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
783,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
784,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
785,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
786,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
786,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
786,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
788,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
789,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
789,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
790,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
791,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
792,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
792,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
793,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
793,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
793,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
794,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
795,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
796,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
797,1,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
797,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,Y
798,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
799,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
800,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
801,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
801,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
802,1,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
803,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
804,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
805,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
806,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
806,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
806,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
807,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
807,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
807,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
807,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
808,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
808,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
809,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
810,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
811,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
812,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
812,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
812,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
813,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
813,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
813,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
814,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
814,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
815,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
816,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
817,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
817,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
817,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
817,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
818,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
818,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
818,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
818,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
818,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
819,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
820,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
820,2,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
821,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
821,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
821,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
822,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
823,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
823,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
824,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
825,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
825,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
825,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
825,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
